Articles related to TYPE 2 DIABETES

Advanced molecular screening methods for colorectal cancer and AI-assisted colonoscopy detection systems represent significant developments in diagnostic technology, potentially improving both accuracy and accessibility of cancer screening programs.

Fresh pineapple demonstrates a moderate glycemic index of 51-66, making it a viable fruit option for diabetic patients when consumed with appropriate portion control and protein pairing strategies.

The combination of structured lifestyle interventions with targeted pharmacotherapy demonstrates significant potential for achieving substantial weight loss in patients with type 2 diabetes.

Ozempic (semaglutide) offers effective glycemic control and weight loss benefits for type 2 diabetes patients, but comes with a range of potential side effects. Physicians should be prepared to discuss common gastrointestinal issues, rare but serious complications, and special considerations for pregnant or postmenopausal patients.

Recent research comparing SGLT2 inhibitors and dulaglutide in older patients with type 2 diabetes suggests a potential difference in dementia risk. The study estimated a risk ratio of 0.81 (CI, 0.56 to 1.16) for SGLT2 inhibitors compared to dulaglutide.

New guidelines endorse the use of continuous glucose monitors and insulin pumps in hospital settings, potentially improving glycemic control while reducing hypoglycemia risk in noncritically ill patients.